Previous Article | Next Article ![]()
Journal of Virology, October 2006, p. 9789-9797, Vol. 80, No. 19
0022-538X/06/$08.00+0 doi:10.1128/JVI.01055-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Yong Xiao,1,3,
Jacques Thibodeau,2,3 and
Éric A. Cohen1,3*
Unité de Rétrovirologie Humaine, Institut de Recherches Cliniques de Montréal, Montréal, Canada,1 Laboratoire d'Immunologie Moléculaire,2 Département de Microbiologie et Immunologie, Université de Montréal, Montréal, Québec, Canada3
Received 22 May 2006/ Accepted 11 July 2006
Human immunodeficiency virus type 1 (HIV-1) assembly, budding, and release occur mostly at the plasma membrane in T lymphocytes as well as in established nonlymphoid cell lines, while in macrophages these processes occur primarily in intracellular compartments that harbor late endosomal/multivesicular body (LE/MVB) markers, including human leukocyte antigen DR (HLA-DR). Major histocompatibility complex class II molecules (MHC-II), which are expressed in macrophages and activated T cells, have been previously reported to induce the formation of multilaminar and multivesicular endocytic MHC-II-like structures analogous to MVB upon their expression in HEK 293 cells. Here, we have examined the role of MHC-II in HIV-1 Gag targeting as well as in virus assembly and release. Expression of HLA-DR in nonlymphoid cell lines induced a relocation of Gag to intracellular compartments that harbored LE/MVB markers and increased the accumulation of viral particles assembling intracellularly. Consequently, viral production and release from the cell surface was found to be substantially decreased in HLA-DR-expressing cells. This process was specific, since it was not observed with HLA-DR molecules lacking their cytoplasmic tails, nor with structurally related but functionally distinct MHC-II molecules such as HLA-DM or HLA-DO. Importantly, virus released intracellularly in HLA-DR-expressing cells retained infectivity. Overall, these results suggest a role of MHC-II molecules in promoting HIV-1 assembly and budding to LE/MVB and raise the possibility that this activity might be part of a normal pathway of virus production in cell types physiologically expressing MHC-II molecules, such as macrophages.
A.B. and Y.X. contributed equally to the work.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|